Who founded EdiTy Therapeutics?

EdiTy Therapeutics was founded by Eyal Kolka, Michal Golan-Mashiach in 2020.

Who are EdiTy Therapeutics's investors?

EdiTy Therapeutics's investors include Loop VC, NFX, Tal Ventures, Blumberg Capital, O.G. Venture Partners.

Where is EdiTy Therapeutics headquartered?

EdiTy Therapeutics is headquartered in Rehovot, IL.

EdiTy Therapeutics

Rehovot, IL · Founded 2020 · 22 employees on LinkedIn · 5 known investors

Find your way into EdiTy Therapeutics

Each arrow is one introduction. Sign up to fill in the first one.

392 people can intro you to Michal

Ask Alexandra (Sandra) Glucksmann to introduce you to Michal Golan-Mashiach

You →Alexandra · together at EdiTy Therapeutics →Michal

Your email: who you already know at EdiTy Therapeutics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the EdiTy Therapeutics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Edity develops an AI-powered platform that engineers therapeutic proteins and uses immune cells (such as T-cells and NK cells) as carriers to deliver them to diseased tissues. Its plug-and-play technology is compatible with allogeneic approaches and aimed at creating new modalities for intracellular therapy.

AI & Machine Learning Biotech Healthtech

Founders & leadership

EdiTy Therapeutics was founded in 2020 by Eyal Kolka and Michal Golan-Mashiach.

Eyal KolkaCo-founder, Chairman of the Board

Michal Golan-Mashiach Founder & CEOMichal Golan-Mashiach holds a Ph.D. in Systems Biology from the Weizmann Institute and brings over 15 years of experience in genetics, bioinformatics, and computational biology, including prior roles as Chief Scientific Officer at Dr. Gene and clinical consultant for diagnostic and gene-editing companies in Israel.

Investors · 5

Loop VClisted by Loop VC

NFXlisted by NFXSan Francisco · $250K – $5M

Tal Ventureslisted by Tal VenturesTel Aviv · $3M – $120M

How we know: Tal Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Blumberg CapitalreportedMiami · $500K – $5M

How we know: a partner's Signal profile · Not right? Tell us

O.G. Venture PartnersreportedTel Aviv-Yafo · $5M – $15M

How we know: a partner's Signal profile · Not right? Tell us

Founder mafia

2 people who came through EdiTy Therapeutics went on to found or lead other companies.

Alexandra (Sandra) GlucksmannBoard MemberFounded Sensorium Therapeutics Omri DroryBoard MemberFounded Renewal Bio

Frequently asked questions

What does EdiTy Therapeutics do?: Edity develops an AI-powered platform that engineers therapeutic proteins and uses immune cells (such as T-cells and NK cells) as carriers to deliver them to diseased tissues. Its plug-and-play technology is compatible with allogeneic approaches and aimed at creating new modalities for intracellular therapy.
Who founded EdiTy Therapeutics?: EdiTy Therapeutics was founded by Eyal Kolka, Michal Golan-Mashiach in 2020.
Who are EdiTy Therapeutics's investors?: EdiTy Therapeutics's investors include Loop VC, NFX, Tal Ventures, Blumberg Capital, O.G. Venture Partners.
Where is EdiTy Therapeutics headquartered?: EdiTy Therapeutics is headquartered in Rehovot, IL.